SEC Form 4 · accession 0001209191-18-037817
Cue Biopharma, Inc. · CUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven L McKnight
Director
Period of report
Jun 12, 2018
Accepted (ET)
Jun 14, 2018 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645460
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $14.24 | Jun 12, 2018 | M | 8,000 | A | Dec 31, 2018 | Jun 12, 2025 | Common Stock | 8,000 | 8,000 | D |